Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma

Cancer

Volumn 100, Issue 12, 2004, Pages 2562-2572

  Hwang, E Shelley ^a   Nyante, Sarah J ^a   Chen, Yunn Yi ^a   Moore, Dan ^b   DeVries, Sandy ^b   Korkola, James E ^b   Esserman, Laura J ^a   Waldman, Frederic M ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast neoplasms; Comparative genomic hybridization; Ductal carcinoma in situ; Lobular carcinoma in situ

Indexed keywords

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BREAST CARCINOMA; CANCER INVASION; CANCER RISK; CARCINOMA IN SITU; CELL CLONE; CHROMOSOME 16Q; CHROMOSOME 1Q; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MICRODISSECTION; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; FEMALE; HUMANS; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION;

EID: 2642517877     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20273     Document Type: Article

References (30)

1. Foote FW Jr., Stewart FW. Lobular carcinoma in situ. Am J Pathol. 1941;17:491-499.
2. Rosen PP, Kosloff C, Lieberman PH, Adair F, Braun DW Jr. Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol. 1978;2:225-251.
3. Page DL, Kidd TE Jr., Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol. 1991;22:1232-1239.
4. Wheeler JE, Enterline HT, Roseman JM, et al. Lobular carcinoma in situ of the breast. Long-term follow up. Cancer. 1974;34:554-563.
5. Frykberg ER, Bland KI. Management of in situ and minimally invasive breast carcinoma. World J Surg. 1994; 18:45-57.
6. Habel LA, Moe RE, Daling JR, Holte S, Rossing MA, Weiss NS. Risk of contralateral breast cancer among women with carcinoma in situ of the breast. Ann Surg. 1997;225:69-75.
7. Ottesen GL, Graversen HP, Blichert-Toft M, Christensen IJ, Andersen JA. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study. Breast Cancer Res Treat. 2000;62:197-210.
8. Gong G, DeVries S, Chew KL, Cha I, Ljung BM, Waldman FM. Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization. Clin Cancer Res. 2001;7:2410-2414.
9. Waldman FM, DeVries S, Chew KL, Moore DH II, Kerlikowske K, Ljung BM. Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. J Natl Cancer Inst. 2000;92:313-320.
10. Ginzinger DG, Godfrey TE, Nigro J, et al. Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res. 2000;60:5405-5409.
11. Pinkel D, Segraves R, Sudar D, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet. 1998;20:207-211.
12. Wilhelm M, Veltman JA, Olshen AB, et al. Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer. Cancer Res. 2002;62:957-960.
13. Veltman JA, Fridlyand J, Pejavar S, et al. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res. 2003; 63:2872-2880.
14. Jain AN, Tokuyasu TA, Snijders AM, Segraves R, Albertson DG, Pinkel D. Fully automatic quantification of microarray image data. Genome Res. 2002;12:325-332.
15. Nemoto T, Castillo N, Tsukada Y, Koul A, Eckhert KH Jr., Bauer RL. Lobular carcinoma in situ with microinvasion. J Surg Oncol. 1998;67:41-46.
16. De Leeuw WJ, Berx G, Vos CB, et al. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol. 1997;183:404-411.
17. Etzell JE, Devries S, Chew K, et al. Loss of chromosome 16q in lobular carcinoma in situ. Hum Pathol. 2001;32:292-296.
18. Moran M, Haffty BG. Lobular carcinoma in situ as a component of breast cancer: the long-term outcome in patients treated with breast-conservation therapy. Int J Radiat Oncol Biol Phys. 1998;40:353-358.
19. Isola JJ, Kallioniemi OP, Chu LW, et al. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol. 1995;147: 905-911.
20. Lu YJ, Osin P, Lakhani SR, Di Palma S, Gusterson BA, Shipley JM. Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res. 1998;58:4721-4727.
21. Waldman FM, Hwang ES, Etzell J, et al. Genomic alterations in tubular breast carcinomas. Hum Pathol. 2001;32:222-226.
22. Thor AD, Eng C, Devries S, et al. Invasive micropapillary carcinoma of the breast is associated with chromosome 8 abnormalities detected by comparative genomic hybridization. Hum Pathol. 2002;33:628-631.
23. Tsuda H, Takarabe T, Hirohashi S. Correlation of numerical and structural status of chromosome 16 with histological type and grade of non-invasive and invasive breast carcinomas. Int J Cancer. 1999;84:381-387.
24. Berx G, Cleton-Jansen AM, Nollet F, et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 1995;14:6107-6115.
25. Tsutsui S, Ohno S, Murakami S, Hachitanda Y, Oda S. Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer. Breast Cancer Res Treat. 2002;71: 67-75.
26. Porter PL, Garcia R, Moe R, Corwin DJ, Gown AM. C-erbB-2 oncogene protein in in situ and invasive lobular breast neoplasia. Cancer. 1991;68:331-334.
27. Mercapide J, Zhang SY, Fan X, et al. CCND1- and ERBB2-gene deregulation and PTEN mutation analyses in invasive lobular carcinoma of the breast. Mol Carcinog. 2002;35:6-12.
28. Olsen SR, Uhler MD. Inhibition of protein kinase-A by overexpression of the cloned human protein kinase inhibitor. Mol Endocrinol. 1991;5:1246-1256.
29. Fisher ER, Costantino J, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ. Cancer. 1996;78:1403-1416.
30. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst. 1998;90:1371-1388.